Retatrutide, a novel dual agonist of the GLP-1 target and glucose-dependent insulinotropic polypeptide (GIP) receptor , is demonstrating promising results in preliminary human studies. Ongoing inquiry https://bookmarkedblog.com/story268391/retatrutide-emerging-research-and-projected-medical-roles